Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Therapeutic potency of oncolytic virotherapy-induced cancer stem cells targeting in brain tumors, current status, and perspectives.

Bahreyni A, Ghorbani E, Fuji H, Ryzhikov M, Khazaei M, Erfani M, Avan A, Hassanian SM, Azadmanesh K.

J Cell Biochem. 2018 Oct 15. doi: 10.1002/jcb.27661. [Epub ahead of print] Review.

PMID:
30321455
2.

Therapeutic potency of oncolytic virotherapy in breast cancer targeting, current status and perspective.

Ebrahimi S, Ghorbani E, Shafiee M, Ryzhikov M, Hassanian SM, Azadmanesh K.

J Cell Biochem. 2018 Sep 27. doi: 10.1002/jcb.27725. [Epub ahead of print] Review.

PMID:
30260014
3.

Targeting pediatric cancer stem cells with oncolytic virotherapy.

Friedman GK, Cassady KA, Beierle EA, Markert JM, Gillespie GY.

Pediatr Res. 2012 Apr;71(4 Pt 2):500-10. doi: 10.1038/pr.2011.58. Epub 2012 Feb 15. Review.

4.

Oncolytic virus as a cancer stem cell killer: progress and challenges.

Ding J.

Stem Cell Investig. 2014 Dec 28;1:22. doi: 10.3978/j.issn.2306-9759.2014.12.02. eCollection 2014. Review.

5.

Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and Mechanisms.

Chaurasiya S, Chen NG, Warner SG.

Cancers (Basel). 2018 Apr 19;10(4). pii: E124. doi: 10.3390/cancers10040124. Review.

6.

Targeting cancer stem cells with oncolytic virus.

Tong Y, Qian W.

Stem Cell Investig. 2014 Nov 28;1:20. doi: 10.3978/j.issn.2306-9759.2014.11.01. eCollection 2014. Review.

7.

Interferon-Mediated Tumor Resistance to Oncolytic Virotherapy.

Ebrahimi S, Ghorbani E, Khazaei M, Avan A, Ryzhikov M, Azadmanesh K, Hassanian SM.

J Cell Biochem. 2017 Aug;118(8):1994-1999. doi: 10.1002/jcb.25917. Epub 2017 Apr 25. Review.

PMID:
28135008
8.

Oncolytic viral therapy: targeting cancer stem cells.

Smith TT, Roth JC, Friedman GK, Gillespie GY.

Oncolytic Virother. 2014 Feb;2014(3):21-33.

9.

Oncolytic adenoviruses targeted to cancer stem cells.

Short JJ, Curiel DT.

Mol Cancer Ther. 2009 Aug;8(8):2096-102. doi: 10.1158/1535-7163.MCT-09-0367. Epub 2009 Aug 11. Review.

10.

GP73-regulated oncolytic adenoviruses possess potent killing effect on human liver cancer stem-like cells.

Zhang X, Meng S, Zhang R, Ma B, Liu T, Yang Y, Xie W, Liu X, Huang F, Liu T, Zhou X, Liu X, Wang Y.

Oncotarget. 2016 May 17;7(20):29346-58. doi: 10.18632/oncotarget.8830.

11.

Targeting autophagy to enhance oncolytic virus-based cancer therapy.

Meng S, Xu J, Wu Y, Ding C.

Expert Opin Biol Ther. 2013 Jun;13(6):863-73. doi: 10.1517/14712598.2013.774365. Epub 2013 Mar 14. Review.

PMID:
23488666
12.

The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid Cancers.

Angelova AL, Witzens-Harig M, Galabov AS, Rommelaere J.

Front Oncol. 2017 May 12;7:93. doi: 10.3389/fonc.2017.00093. eCollection 2017.

13.

Oncolytic Viruses in Cancer Treatment: A Review.

Lawler SE, Speranza MC, Cho CF, Chiocca EA.

JAMA Oncol. 2017 Jun 1;3(6):841-849. doi: 10.1001/jamaoncol.2016.2064. Review.

PMID:
27441411
14.

Fighting Cancer with Viruses: Oncolytic Virus Therapy in China.

Wei D, Xu J, Liu XY, Chen ZN, Bian H.

Hum Gene Ther. 2018 Feb;29(2):151-159. doi: 10.1089/hum.2017.212.

PMID:
29284308
15.

Advances in the mechanisms of action of cancer-targeting oncolytic viruses.

Lin CZ, Xiang GL, Zhu XH, Xiu LL, Sun JX, Zhang XY.

Oncol Lett. 2018 Apr;15(4):4053-4060. doi: 10.3892/ol.2018.7829. Epub 2018 Jan 19.

16.

Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer.

Huang F, Wang BR, Wu YQ, Wang FC, Zhang J, Wang YG.

World J Gastroenterol. 2016 Sep 21;22(35):7999-8009. doi: 10.3748/wjg.v22.i35.7999. Review.

17.

Bugs and drugs: oncolytic virotherapy in combination with chemotherapy.

Wennier ST, Liu J, McFadden G.

Curr Pharm Biotechnol. 2012 Jul;13(9):1817-33. Review.

18.

NF-κB Signaling in Targeting Tumor Cells by Oncolytic Viruses-Therapeutic Perspectives.

Struzik J, Szulc-Dąbrowska L.

Cancers (Basel). 2018 Nov 8;10(11). pii: E426. doi: 10.3390/cancers10110426. Review.

19.

Immune System, Friend or Foe of Oncolytic Virotherapy?

Filley AC, Dey M.

Front Oncol. 2017 May 23;7:106. doi: 10.3389/fonc.2017.00106. eCollection 2017. Review.

20.

Targeting tumor vasculature through oncolytic virotherapy: recent advances.

Toro Bejarano M, Merchan JR.

Oncolytic Virother. 2015 Nov 11;4:169-81. doi: 10.2147/OV.S66045. eCollection 2015. Review.

Supplemental Content

Support Center